≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Immunodeficiency with predominantly antibody defects

DOID MESH PheWeb

D3_IMMUDEFANTIBODY

No definition available.

Endpoint definition

↥
FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D80
Cause of death: ICD-10 D80

2 out of 7 registries used, show all original rules.

722

diagram downward connector

Check minimum number of events None

722

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

742

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

711

diagram downward connector
D3_IMMUDEFANTIBODY

Control definitions

Control exclude D3_IMMUNEMECHANISM

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D80-D89
Name in latin Deficientia immunalis praecipue cum vitiis anticorporum

Similar endpoints

↥

List of similar endpoints to Immunodeficiency with predominantly antibody defects based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 711 469 242
Unadjusted prevalence (%) 0.19 0.22 0.15
Mean age at first event (years) 46.24 45.76 47.16

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.26 18.79 [9.55, 36.95] 1.9e-17 62
15 years 0.05 7.10 [3.55, 14.19] 2.9e-8 22
5 years 0.02 17.37 [9.78, 30.87] 2.1e-22 25
1 year 0.01 40.15 [19.71, 81.80] 2.7e-24 13

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_IMMUDEFANTIBODY – Immunodeficiency with predominantly antibody defects
GWS hits:

Survival analyses between endpoints

↥

Plot

before Immunodeficiency with predominantly antibody defects
after Immunodeficiency with predominantly antibody defects

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Immunodeficiency with predominantly antibody defects

↥

Endpoint not on priority list, no data to show.